KIM MCCOY: Open Payments
NPI 1568858223 · MELROSE PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 44 payments from 13 companies in 2025. Trend: 2023 $1,173 · 2024 $1,314 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $357 |
| Otsuka America Pharmaceutical, Inc. | 9 | $350 |
| Janssen Pharmaceuticals, Inc | 5 | $287 |
| Lundbeck LLC | 5 | $97 |
| Luye Pharma (USA) Ltd. | 3 | $76 |
| Alkermes, Inc. | 2 | $51 |
| MERZ NORTH AMERICA, INC. | 1 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, LYBALVI, DUPIXENT.
Industry payments across IL — which companies pay providers there.
